Skip to main content
All lobbying filings

CAMBIA HEALTH SOLUTIONS

Lobbying for CAMBIA HEALTH SOLUTIONS

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 21, 2025
Expenses
$620,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Lobbyists on this filing 1
  • RYNE CARNEY
    Previously held: Intern - Rep. Ed Perlmutter

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2
Health Issues

Affordable Care Act - extending enhanced APTCs (H.R. 257; S. 46) and fraudulent enrollments in qualified health plans (S. 976), Individual Coverage Health Reimbursement Arrangements, Behavioral Health, Employer-Provided Health Coverage, Surprise Billing, Cybersecurity, Health IT, Health Care Innovation, Transparency & PBMs (S. 891, Sec. 901, Sec. 902), Prescription Drugs (S. 1096, S.1040), Telehealth Extending Flexibilities (S. 891, Sec. 1001)

Medicare/Medicaid

Medicare Advantage (Star Ratings, Risk Adjustment, Health Equity Index, Supplemental Benefits), Medicare Prior Authorization and Electronic Prior Authorization, Provider Directories (S. 891, Sec. 223), Telehealth Extending Flexibilities (H.R. 1968, Sec. 2207), Transparency & PBMs (S. 882; S. 891, Sec. 227), Physician Fee Schedule (S. 891, S. 205), Site Neutrality & Provider Billing (S. 891, Sec. 228), Medicare Coverage & Obesity, FY25 Concurrent Budget Resolution (potential Medicare and Medicaid Policies)

 Bills named in this filing 9
  • H.R. 257
    SEC Act of 2025
  • S. 46
    Health Care Affordability Act of 2025
  • S. 976
    Insurance Fraud Accountability Act
  • S. 891
    Bipartisan Health Care Act
  • S. 1096
    Preserve Access to Affordable Generics and Biosimilars Act
  • S. 1040
    Drug Competition Enhancement Act
  • H.R. 1968
    To provide for a limitation on availability of funds for Department of Health and Human Services, Centers for Disease C…
  • S. 882
    Patients Before Middlemen Act
  • S. 205
    Protecting Individuals with Down Syndrome Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem